BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34235809)

  • 21. Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns.
    Aggarwal N; Yadav J; Thakur K; Bibban R; Chhokar A; Tripathi T; Bhat A; Singh T; Jadli M; Singh U; Kashyap MK; Bharti AC
    Front Cell Infect Microbiol; 2020; 10():537650. PubMed ID: 33344262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of computed tomography in identifying extranodal extension in human papillomavirus-positive versus human papillomavirus-negative head and neck cancer.
    Yan F; Byun YJ; Nguyen SA; Stalcup ST; Day TA
    Head Neck; 2020 Sep; 42(9):2687-2695. PubMed ID: 32484583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies.
    Ghiani L; Chiocca S
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.
    Spanos WC; Nowicki P; Lee DW; Hoover A; Hostager B; Gupta A; Anderson ME; Lee JH
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1137-46. PubMed ID: 19917928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy.
    Moeller BJ; Yordy JS; Williams MD; Giri U; Raju U; Molkentine DP; Byers LA; Heymach JV; Story MD; Lee JJ; Sturgis EM; Weber RS; Garden AS; Ang KK; Schwartz DL
    Clin Cancer Res; 2011 Apr; 17(7):2035-43. PubMed ID: 21349997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subjugation of TGFβ Signaling by Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma Shifts DNA Repair from Homologous Recombination to Alternative End Joining.
    Liu Q; Ma L; Jones T; Palomero L; Pujana MA; Martinez-Ruiz H; Ha PK; Murnane J; Cuartas I; Seoane J; Baumann M; Linge A; Barcellos-Hoff MH
    Clin Cancer Res; 2018 Dec; 24(23):6001-6014. PubMed ID: 30087144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient derived ex vivo tissue slice cultures demonstrate a profound DNA double-strand break repair defect in HPV-positive oropharyngeal head and neck cancer.
    Zech HB; Berger J; Mansour WY; Nordquist L; von Bargen CM; Bußmann L; Oetting A; Christiansen S; Möckelmann N; Böttcher A; Busch CJ; Petersen C; Betz C; Rothkamm K; Kriegs M; Köcher S; Rieckmann T
    Radiother Oncol; 2022 Mar; 168():138-146. PubMed ID: 35093407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The tumor immune microenvironments of HPV
    Gameiro SF; Evans AM; Mymryk JS
    WIREs Mech Dis; 2022 Mar; 14(2):e1539. PubMed ID: 35030304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.
    Wang Y; Wang J; Huang Y
    Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity.
    Nickson CM; Moori P; Carter RJ; Rubbi CP; Parsons JL
    Oncotarget; 2017 May; 8(18):29963-29975. PubMed ID: 28415784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.
    Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B
    Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
    Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
    J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity.
    Rieckmann T; Tribius S; Grob TJ; Meyer F; Busch CJ; Petersen C; Dikomey E; Kriegs M
    Radiother Oncol; 2013 May; 107(2):242-6. PubMed ID: 23602369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis.
    Xu Y; Zhu G; Maroun CA; Wu IXY; Huang D; Seiwert TY; Liu Y; Mandal R; Zhang X
    Front Immunol; 2021; 12():645170. PubMed ID: 33897693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative diffusion magnetic resonance imaging for prediction of human papillomavirus status in head and neck squamous-cell carcinoma: A systematic review and meta-analysis.
    Payabvash S; Chan A; Jabehdar Maralani P; Malhotra A
    Neuroradiol J; 2019 Aug; 32(4):232-240. PubMed ID: 31084347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of differences in radiation-induced immunogenicity parameters between HPV-positive and HPV-negative human HNSCC cell lines.
    Schneider K; Bol V; Grégoire V
    Radiother Oncol; 2017 Sep; 124(3):411-417. PubMed ID: 28916224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of Glial cell derived neurotrophic factor in head and neck cancer.
    Cao H; He Q; Eyben RV; Bloomstein J; Nambiar DK; Viswanathan V; Aggarwal S; Kwok S; Liang R; Koong AJ; Lewis JS; Kong C; Xiao N; Le QT
    PLoS One; 2020; 15(2):e0229311. PubMed ID: 32084217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent Human Papillomavirus-Related Head and Neck Cancer Undergoes Metabolic Reprogramming and Is Driven by Oxidative Phosphorylation.
    Vyas A; Harbison RA; Faden DL; Kubik M; Palmer D; Zhang Q; Osmanbeyoglu HU; Kiselyov K; Méndez E; Duvvuri U
    Clin Cancer Res; 2021 Nov; 27(22):6250-6264. PubMed ID: 34407971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of additional HPV diagnostics in 102 patients with p16-stratified advanced oropharyngeal squamous cell carcinoma.
    Weiss BG; Anczykowski MZ; Küffer S; Spiegel JL; Bertlich M; Canis M; Ihler F; Kitz J; Jakob M
    Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1983-2000. PubMed ID: 32814982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas.
    Driessen JP; van Bemmel AJ; van Kempen PM; Janssen LM; Terhaard CH; Pameijer FA; Willems SM; Stegeman I; Grolman W; Philippens ME
    Head Neck; 2016 Apr; 38 Suppl 1():E613-8. PubMed ID: 25783872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.